Answers are grounded in this paper and cite their sources.
The rate of serious cardiovascular events among participants receiving maintenance hemodialysis was lower with daily supplementation with n-3 fatty acids than with placebo. (Supported by the Heart and Stroke Foundation of Canada and others; PISCES ClinicalTrials.gov number, ISRCTN00691795.).
No takes yet. Share an insight, caveat, or question.
Lok et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: